JPS5535049A - Amino acid transfusion for cancerous patient - Google Patents

Amino acid transfusion for cancerous patient

Info

Publication number
JPS5535049A
JPS5535049A JP10874978A JP10874978A JPS5535049A JP S5535049 A JPS5535049 A JP S5535049A JP 10874978 A JP10874978 A JP 10874978A JP 10874978 A JP10874978 A JP 10874978A JP S5535049 A JPS5535049 A JP S5535049A
Authority
JP
Japan
Prior art keywords
amino acid
transfusion
methionine
acid transfusion
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10874978A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6154007B2 (enExample
Inventor
Koji Koseki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Co Ltd
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd, Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP10874978A priority Critical patent/JPS5535049A/ja
Priority to GB7929789A priority patent/GB2029220B/en
Priority to AU50368/79A priority patent/AU526207B2/en
Priority to CA334,841A priority patent/CA1134275A/en
Priority to IT05216/79A priority patent/IT1194844B/it
Priority to SE7907316A priority patent/SE448679B/sv
Priority to FR7921975A priority patent/FR2434622A1/fr
Priority to NLAANVRAGE7906620,A priority patent/NL190266C/xx
Priority to DE2935709A priority patent/DE2935709C2/de
Priority to CH799179A priority patent/CH642541A5/de
Publication of JPS5535049A publication Critical patent/JPS5535049A/ja
Publication of JPS6154007B2 publication Critical patent/JPS6154007B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10874978A 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient Granted JPS5535049A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient
GB7929789A GB2029220B (en) 1978-09-04 1979-08-28 Amino acid solutions for patients with cancers
AU50368/79A AU526207B2 (en) 1978-09-04 1979-08-29 Amino acid solutions as food for patients with cancer
CA334,841A CA1134275A (en) 1978-09-04 1979-08-31 Amino acid solutions for patients with cancers
IT05216/79A IT1194844B (it) 1978-09-04 1979-09-03 Soluzione di amminoacidi per pazienti affetti da carcinoma
SE7907316A SE448679B (sv) 1978-09-04 1979-09-03 Infusionslosning for patienter med cancer innehallande essentiella aminosyror men er fri fran metionin
FR7921975A FR2434622A1 (fr) 1978-09-04 1979-09-03 Solutions d'acides amines destinees a l'alimentation de patients atteints de cancer
NLAANVRAGE7906620,A NL190266C (nl) 1978-09-04 1979-09-04 Aminozuuroplossing voor kankerpatienten.
DE2935709A DE2935709C2 (de) 1978-09-04 1979-09-04 Aminosäurelösung zur Behandlung von an Krebs erkrankten Personen
CH799179A CH642541A5 (de) 1978-09-04 1979-09-04 Essentielle aminosaeuren enthaltende loesung zur verabreichung an krebspatienten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10874978A JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Publications (2)

Publication Number Publication Date
JPS5535049A true JPS5535049A (en) 1980-03-11
JPS6154007B2 JPS6154007B2 (enExample) 1986-11-20

Family

ID=14492527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10874978A Granted JPS5535049A (en) 1978-09-04 1978-09-04 Amino acid transfusion for cancerous patient

Country Status (10)

Country Link
JP (1) JPS5535049A (enExample)
AU (1) AU526207B2 (enExample)
CA (1) CA1134275A (enExample)
CH (1) CH642541A5 (enExample)
DE (1) DE2935709C2 (enExample)
FR (1) FR2434622A1 (enExample)
GB (1) GB2029220B (enExample)
IT (1) IT1194844B (enExample)
NL (1) NL190266C (enExample)
SE (1) SE448679B (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813512A (ja) * 1981-07-03 1983-01-26 シャルル・シャニ Ｃ↓１−ｃ↓６カルボン酸と塩基性アミノ酸との反応生成物を含む薬剤
EP0560989A4 (enExample) * 1991-10-07 1994-02-02 Otsuka Pharmaceutical Factory, Inc.
JPH07501083A (ja) * 1992-08-29 1995-02-02 ウエラ　アクチェンゲゼルシャフト リグニンまたはリグニン誘導体に基づく毛髪セット剤ならびにジヒドロキシプロピルリグニン
JP2005518361A (ja) * 2001-11-27 2005-06-23 ブルジンスキー，スタニスロー・アール 細胞傷害的化学療法の毒性作用を軽減するために有用な、アミノ酸およびリボフラビンの配合物
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500526A (ja) * 1981-04-17 1983-04-07 アメリカン　ホスピタル　サプライ　コ−ポレ−シヨン 非経口栄養供給のための改良溶液
DE3329253A1 (de) * 1983-08-12 1985-02-21 Milupa Ag, 6382 Friedrichsdorf Verwendung eines aminosaeuregemisches zur bekaempfung insbesondere von lymphadenomen
HU191598B (en) * 1984-03-20 1987-03-30 Egyt Gyogyszervegyeszeti Gyar Method for the preparation of injection solution suitable preferably against cathosis
DE3440090A1 (de) * 1984-11-02 1986-05-07 Novo-Med AG, Appenzell Aminosaeureloesungen enthaltendes arzneimittel zur therapie von krebserkrankungen und verfahren zu seiner herstellung
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
FR2591893B1 (fr) * 1985-12-19 1988-11-10 Centre Nat Rech Scient Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
GB8917660D0 (en) * 1989-08-02 1989-09-20 Rana Ashok S J Prophylaxis of transurethral resection reactions
US5658895A (en) * 1991-10-07 1997-08-19 Otsuka Pharmaceutical Factory, Inc. Anticancer enteral feeding composition
ES2184756T3 (es) * 1992-11-19 2003-04-16 Anticancer Inc Uso de metioninasa como agente antitumoral en quimioterapia antimetionina.
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
RU2125874C1 (ru) * 1994-07-04 1999-02-10 Казанский государственный университет им.В.И.Ульянова-Ленина Композиция аминокислот с микроэлементами, обладающая противоопухолевой и антигипоксической активностью
JP2000515874A (ja) * 1996-07-30 2000-11-28 ノバルテイス・ニユートリシヨン・アクチエンゲゼルシヤフト アミノ酸組成物、ならびに腫瘍の成長および転移の処置におけるその使用
EP1068868A3 (en) * 1997-07-08 2001-01-31 Rath, Matthias, Dr. med. Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
RU2144821C1 (ru) * 1999-02-16 2000-01-27 Товарищество с ограниченной ответственностью Фирма "ГЛЕС" Противоопухолевое средство
ATE323479T1 (de) * 2000-06-16 2006-05-15 Matthias Dr Med Rath Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
DE60028376T2 (de) * 2000-10-09 2007-06-06 Rath, Matthias, Dr. Therapeutische Kombination des Ascorbats mit Lysin und Arginin für Verhinderung und Behandlung des Krebses
US6974833B2 (en) 2001-01-16 2005-12-13 Matthias Rath Synergistic compositions comprising ascobate and lysine for states related to extra cellular matrix degeneration
US6686340B2 (en) 2001-06-19 2004-02-03 Matthias Rath Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells
SG106614A1 (en) * 2001-06-21 2004-10-29 Matthias Rath Dr Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003030890A1 (fr) * 2001-10-05 2003-04-17 Tetsuro Asao Activateurs du systeme immunitaire
US20050053664A1 (en) 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
JP2007529554A (ja) * 2004-03-19 2007-10-25 プロ−ファーマシューティカルズ，インク． 多価リガンド結合糖質ポリマーを用いた組成物、および該組成物による転移腫瘍の標的療法
WO2007016954A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing drug or alcohol induced breast cancer risk
WO2007016950A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced neurodegenerative disease
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy
WO2007016952A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risk of alcohol induced esophagenal and oropharyngolaryngeal cancer
WO2007016953A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
WO2007016951A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced pancreatic cancer
KR101487848B1 (ko) 2005-07-29 2015-02-03 티마 파운데이션 알콜대사를 완화하고 알콜유도성 질환의 위험을 감소하기 위한 조성물
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
ES2891733T3 (es) 2007-03-28 2022-01-31 Univ Southern California Inducción de la resistencia diferencial al estrés y usos de la misma
EP2285218B1 (en) * 2008-04-24 2020-06-17 University Of Southern California, USC Stevens Dietary compositions and methods for protection against chemotherapy or radiotherapy
EP2676664B1 (en) * 2011-02-17 2017-06-21 EA Pharma Co., Ltd. Potentiator of antitumor activity of chemotherapeutic agent
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
BR112020002419A2 (pt) 2017-08-14 2020-07-28 Axcella Health Inc. aminoácido para o tratamento de doença do fígado
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
IT202000000454A1 (it) * 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro
IT202000000442A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT297935B (de) * 1968-05-09 1972-04-10 Astra Ab Verfahren zur Herstellung einer Infusionslösung von essentiellen Aminosäuren zur intravenösen Zufuhr bei urämischen Zuständen
SU423304A3 (enExample) * 1970-03-10 1974-04-05 Тейзо Хигаси, Дзинносуке Лбе, Теруо Таке, Сусуми Ватанабе , Масару Отани
DE2013026C3 (de) * 1970-03-19 1981-01-29 Wagner, Karl-Heinz, Prof. Dr.Med.Habil., 6300 Giessen Mittel zur Behandlung und Verhütung von Leberkrankheiten und muskulärer Insuffizienz
DE2530246A1 (de) * 1975-07-07 1977-01-13 Fresenius Chem Pharm Ind L-aminosaeuregemische fuer parenterale oder orale anwendung
DE2531204C2 (de) * 1975-07-12 1987-01-22 Fresenius AG, 6380 Bad Homburg L-Aminosäuregemische für die parenterale oder orale Ernährung

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813512A (ja) * 1981-07-03 1983-01-26 シャルル・シャニ Ｃ↓１−ｃ↓６カルボン酸と塩基性アミノ酸との反応生成物を含む薬剤
EP0560989A4 (enExample) * 1991-10-07 1994-02-02 Otsuka Pharmaceutical Factory, Inc.
JPH07501083A (ja) * 1992-08-29 1995-02-02 ウエラ　アクチェンゲゼルシャフト リグニンまたはリグニン誘導体に基づく毛髪セット剤ならびにジヒドロキシプロピルリグニン
JP2005518361A (ja) * 2001-11-27 2005-06-23 ブルジンスキー，スタニスロー・アール 細胞傷害的化学療法の毒性作用を軽減するために有用な、アミノ酸およびリボフラビンの配合物
JP2016117702A (ja) * 2014-12-22 2016-06-30 武輝 山田 ガン細胞の死滅法

Also Published As

Publication number Publication date
CA1134275A (en) 1982-10-26
SE448679B (sv) 1987-03-16
AU5036879A (en) 1980-03-13
DE2935709A1 (de) 1980-03-13
NL190266C (nl) 1994-01-03
IT7905216A0 (it) 1979-09-03
AU526207B2 (en) 1982-12-23
JPS6154007B2 (enExample) 1986-11-20
GB2029220B (en) 1983-03-30
CH642541A5 (de) 1984-04-30
NL190266B (nl) 1993-08-02
FR2434622B1 (enExample) 1983-04-15
IT1194844B (it) 1988-09-28
NL7906620A (nl) 1980-03-06
FR2434622A1 (fr) 1980-03-28
DE2935709C2 (de) 1986-02-06
GB2029220A (en) 1980-03-19
SE7907316L (sv) 1980-03-05

Similar Documents

Publication Publication Date Title
JPS5535049A (en) Amino acid transfusion for cancerous patient
JPS56110617A (en) Nutrient composition for young child
NZ218734A (en) Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid)
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
JPS5386089A (en) Preparation of l-lysine by fermentation
JPS5386090A (en) Preparation of l-lysine by fermentation
JPS57136596A (en) Carcinostatic substance tf-240, its preparation, and carcinostatic agent containing the same
JPS53107479A (en) Preparation of human lysozyme
JPS5391189A (en) Preparation of d-n-carbamoyl-alpha-amino acids
JPS5648857A (en) Low-protein feed
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
JPS5668374A (en) Food composition for hepatic insufficiency
IL68085A0 (en) 3-acyl derivatives of 2-or 4-thiazolidine carboxylic acid,their preparation and their use as plant-growth regulants
JPS52128288A (en) Glucose isomerase solution
JPS54157838A (en) Preventive for cerebral apoplexy
JPS5411233A (en) Anitidote
JPS542398A (en) Preparation of d-alpha-amino acid
JPS5328119A (en) Preparation of pantetheine
ES8501734A1 (es) Un procedimiento para preparar derivados de cicloalquenilo
JPS5257129A (en) Process for hydroquinone
JPS5227766A (en) Synthesis of human gastrin i
GB1499778A (en) Treatment of swine dysentery
JPS5312491A (en) Preparation of l-alginine by fermentation
JPS646084A (en) Latent heat-type heat storage material
JPS532432A (en) Preparation of resorcin